US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amylyx Pharmaceuticals

5.06

+0.14002.85%

Post-market: 5.060.00000.00%16:05 EDT

Volume:1.08M

Turnover:5.56M

Market Cap:448.33M

PE:-1.14

High:5.24

Open:5.07

Low:4.90

Close:4.92

Loading ...

Overview Company News Filings

Little Excitement Around Amylyx Pharmaceuticals, Inc.'s (NASDAQ:AMLX) Revenues As Shares Take 26% Pounding

Simply Wall St.

Amylyx Pharmaceuticals Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Amylyx Pharmaceuticals Shares up 1.7% on Late-Stage Trial Update for Low-Blood Sugar Drug

THOMSON REUTERS

BUZZ-Amylyx rises on late-stage trial update for low-blood sugar drug

BRIEF-Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia

Amylyx announces design of LUCIDITY clinical trial

Amylyx Pharmaceuticals Announces Pivotal Phase 3 Lucidity Trial Design for Glp-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia

THOMSON REUTERS

Amylyx Pharmaceuticals Inc - First Participant in Lucidity Trial Expected in Q1 2025

THOMSON REUTERS

Amylyx Pharmaceuticals to Present at the 7th Annual Evercore ISI HealthCONx Conference

Baird Upgrades Amylyx Pharmaceuticals to Outperform From Neutral, Adjusts Price Target to $11 From $3

MT Newswires Live

Amylyx Pharmaceuticals Raised to Outperform From Neutral by Baird

Amylyx Pharmaceuticals Third Quarter 2024 Earnings: US$1.07 loss per share (vs US$0.31 profit in 3Q 2023)

Simply Wall St.

Amylyx Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Amylyx Pharmaceuticals Inc (AMLX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...

Q3 2024 Amylyx Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents

Amylyx Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary

BRIEF-Amylyx Pharmaceuticals Reports Q3 2024 Financial Results

Amylyx Pharma Q3 2024 Adj. EPS $(0.53) Beats $(0.71) Estimate, Sales $416.000K Down From $102.693M YoY

Amylyx Pharmaceuticals Inc: Cash Runway Expected Into 2026

THOMSON REUTERS

Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AMLX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AMLX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMLX\",,,,,undefined,":{"symbol":"AMLX","market":"US","secType":"STK","nameCN":"Amylyx Pharmaceuticals","latestPrice":5.06,"timestamp":1745438400000,"preClose":4.92,"halted":0,"volume":1082616,"hourTrading":{"tag":"盘后","latestPrice":5.06,"preClose":5.06,"latestTime":"16:05 EDT","volume":6100,"amount":30865.999999999996,"timestamp":1745438709081},"delay":0,"floatShares":58959874,"shares":88602468,"eps":-4.43,"marketStatus":"Post-Mkt","change":0.14,"latestTime":"04-23 17:32:16 EDT","open":5.07,"high":5.235,"low":4.9,"amount":5560953.60924,"amplitude":0.068089,"askPrice":5.21,"askSize":60,"bidPrice":5.04,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-4.43,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745452800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1641531600000,"exchange":"NASDAQ","adjPreClose":4.92,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":5.0654,"preClose":4.92,"latestTime":"09:09 EDT","volume":245,"amount":1208.098087,"timestamp":1745413741124},"postHourTrading":{"tag":"盘后","latestPrice":5.06,"preClose":5.06,"latestTime":"16:05 EDT","volume":6100,"amount":30865.999999999996,"timestamp":1745438709081},"volumeRatio":1.214343,"impliedVol":1.3332,"impliedVolPercentile":0.72},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMLX\",,,,,undefined,":{"symbol":"AMLX","floatShares":58959874,"roa":"-51.31%","roe":"-100.88%","lyrEps":-4.428139,"volumeRatio":1.214343,"shares":88602468,"dividePrice":1.35477,"high":5.235,"amplitude":0.068089,"preClose":4.92,"low":4.9,"week52Low":1.575,"pbRate":"2.72","psRate":"5.13","week52High":7.27,"institutionHeld":0,"latestPrice":5.06,"committee":-0.935484,"eps":-4.43,"divideRate":0.267741,"volume":1082616,"delay":0,"ttmEps":-4.43,"open":5.07,"prevYearClose":3.78,"prevWeekClose":3.98,"prevMonthClose":3.54,"prevQuarterClose":3.54,"fiveDayClose":3.88,"twentyDayClose":3.78,"sixtyDayClose":3.49},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AMLX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2492450767","title":"Little Excitement Around Amylyx Pharmaceuticals, Inc.'s (NASDAQ:AMLX) Revenues As Shares Take 26% Pounding","url":"https://stock-news.laohu8.com/highlight/detail?id=2492450767","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492450767?lang=en_us&edition=fundamental","pubTime":"2024-12-20 03:08","pubTimestamp":1734635293,"startTime":"0","endTime":"0","summary":"The Amylyx Pharmaceuticals, Inc. ( NASDAQ:AMLX ) share price has softened a substantial 26% over the previous 30 days...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amlx/amylyx-pharmaceuticals/news/little-excitement-around-amylyx-pharmaceuticals-incs-nasdaqa","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AMLX","NDAQ",".IXIC"],"gpt_icon":0},{"id":"2489006430","title":"Amylyx Pharmaceuticals Price Target Maintained With a $12.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2489006430","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489006430?lang=en_us&edition=fundamental","pubTime":"2024-12-05 20:17","pubTimestamp":1733401020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AMLX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 05, 2024 07:17 ET (12:17 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX"],"gpt_icon":0},{"id":"2488419752","title":"Amylyx Pharmaceuticals Shares up 1.7% on Late-Stage Trial Update for Low-Blood Sugar Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2488419752","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488419752?lang=en_us&edition=fundamental","pubTime":"2024-12-04 22:50","pubTimestamp":1733323836,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nFWN3N51SB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2488193730","title":"BUZZ-Amylyx rises on late-stage trial update for low-blood sugar drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2488193730","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488193730?lang=en_us&edition=fundamental","pubTime":"2024-12-04 21:16","pubTimestamp":1733318218,"startTime":"0","endTime":"0","summary":"BUZZ-Amylyx rises on late-stage trial update for low-blood sugar drug** Shares of drug developer Amylyx Pharmaceuticals AMLX.O rise 1.9% to $5.45 premarket** Co announces late-stage trial design for its experimental GLP-1 antagonist treatment, avexitide, to treat a type of low blood sugar called post-bariatric hypoglycemia      ** PBH is a condition that affects approximately 8% of people who have undergone bariatric surgery- AMLX  ** The trial is designed to evaluate FDA-agreed upon primary goal of reduction in hypoglycemia or low blood sugar events- AMLX** Co expects to dose the first study participant in the first quarter of 2025, followed by expected completion of recruitment in 2025, and anticipates topline data in 2026** The late-stage trial will test the efficacy and safety of avexitide in participants with PBH following gastric bypass surgery** Up to last close, stock was down 63.7% YTD   ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nL3N3N50X0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2488198384","title":"BRIEF-Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2488198384","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488198384?lang=en_us&edition=fundamental","pubTime":"2024-12-04 20:48","pubTimestamp":1733316501,"startTime":"0","endTime":"0","summary":"BRIEF-Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric HypoglycemiaDec 4 (Reuters) - Amylyx Pharmaceuticals Inc AMLX.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nTUA9LFPBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2488160219","title":"Amylyx announces design of LUCIDITY clinical trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2488160219","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488160219?lang=en_us&edition=fundamental","pubTime":"2024-12-04 20:35","pubTimestamp":1733315734,"startTime":"0","endTime":"0","summary":"Amylyx (AMLX) announced the design of its pivotal Phase 3 LUCIDITY clinical trial for avexitide, an investigational, first-in-class glucagon-like p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amylyx-announces-design-of-lucidity-clinical-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amylyx-announces-design-of-lucidity-clinical-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2488167762","title":"Amylyx Pharmaceuticals Announces Pivotal Phase 3 Lucidity Trial Design for Glp-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2488167762","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488167762?lang=en_us&edition=fundamental","pubTime":"2024-12-04 20:30","pubTimestamp":1733315400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nTUA9LFPBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2488167007","title":"Amylyx Pharmaceuticals Inc - First Participant in Lucidity Trial Expected in Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2488167007","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488167007?lang=en_us&edition=fundamental","pubTime":"2024-12-04 20:30","pubTimestamp":1733315400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nTUA9LFPBH:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2486824232","title":"Amylyx Pharmaceuticals to Present at the 7th Annual Evercore ISI HealthCONx Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2486824232","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486824232?lang=en_us&edition=fundamental","pubTime":"2024-11-27 22:00","pubTimestamp":1732716000,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., November 27, 2024----Amylyx Pharmaceuticals, Inc.   today announced that management will participate in the 7th Annual Evercore ISI HealthCONx Conference. The conference is being conducted in-person in Coral Gables, Florida, and the fireside chat will take place on Wednesday, December 4, 2024, at 11:15 a.m. ET.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/G9TEU4A0M.u4fFNBymrg3A--~B/aD01ODg7dz0yNTE3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/07a59c3a37255a7ea2f3dcbb46c3f3a7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/G9TEU4A0M.u4fFNBymrg3A--~B/aD01ODg7dz0yNTE3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/07a59c3a37255a7ea2f3dcbb46c3f3a7"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amylyx-pharmaceuticals-present-7th-annual-140000031.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2484621214","title":"Baird Upgrades Amylyx Pharmaceuticals to Outperform From Neutral, Adjusts Price Target to $11 From $3","url":"https://stock-news.laohu8.com/highlight/detail?id=2484621214","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484621214?lang=en_us&edition=fundamental","pubTime":"2024-11-18 20:39","pubTimestamp":1731933588,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals (AMLX) has an average hold rating and a price target range of $3 to $12, according to analysts polled by Capital IQ.(MT Newswires covers equity, commodity and economic research ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AMLX"],"gpt_icon":0},{"id":"2484762191","title":"Amylyx Pharmaceuticals Raised to Outperform From Neutral by Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2484762191","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484762191?lang=en_us&edition=fundamental","pubTime":"2024-11-18 20:36","pubTimestamp":1731933360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AMLX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 18, 2024 07:36 ET (12:36 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX"],"gpt_icon":0},{"id":"2482421743","title":"Amylyx Pharmaceuticals Third Quarter 2024 Earnings: US$1.07 loss per share (vs US$0.31 profit in 3Q 2023)","url":"https://stock-news.laohu8.com/highlight/detail?id=2482421743","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482421743?lang=en_us&edition=fundamental","pubTime":"2024-11-09 22:56","pubTimestamp":1731164188,"startTime":"0","endTime":"0","summary":"NasdaqGS:AMLX Earnings and Revenue Growth November 9th 2024. All figures shown in the chart above are for the trailing 12 month  period. Looking ahead, revenue is expected to decline by 79% p.a. on average during the next 3 years, while revenues in the Pharmaceuticals industry in the US are expected to grow by 10%.The company's shares are up 19% from a week ago.We don't want to rain on the parade too much, but we did also find 2 warning signs for Amylyx Pharmaceuticals that you need to be mindful of.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amylyx-pharmaceuticals-third-quarter-2024-145628080.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AMLX"],"gpt_icon":0},{"id":"2481174719","title":"Amylyx Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2481174719","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481174719?lang=en_us&edition=fundamental","pubTime":"2024-11-08 20:46","pubTimestamp":1731069960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AMLX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 08, 2024 07:46 ET (12:46 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX"],"gpt_icon":0},{"id":"2481974145","title":"Amylyx Pharmaceuticals Inc (AMLX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2481974145","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481974145?lang=en_us&edition=fundamental","pubTime":"2024-11-08 15:11","pubTimestamp":1731049873,"startTime":"0","endTime":"0","summary":"Cash and Investments: $234.4 million at the end of Q3 2024.Net Product Revenues: $400,000 for the third quarter.Cost of Sales: $800,000 related to discontinued commercial sales.Research and Development Expenses: $21.2 million for Q3 2024, down from $30 million in Q3 2023.Selling, General and Administrative Expenses: $17.8 million for Q3 2024, down from $48.7 million in Q3 2023.Acquisition Expense: $36.2 million related to the avexitide acquisition.Net Loss: $72.7 million or $7 per share for the third quarter.GuruFocus has detected 3 Warning Signs with AMLX.Amylyx Pharmaceuticals Inc  has a strong financial position with a cash runway expected to last into 2026.A: Joshua Cohen, Co-CEO, explained that there are approximately 160,000 people living with PBH, based on literature suggesting 20% to 40% of bariatric surgery patients show abnormal glycemic control. About 8% of these patients have persistent PBH. Camille L. Bedrosian, Chief Medical Officer, added that they are actively working w","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amylyx-pharmaceuticals-inc-amlx-q3-071113392.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AMLX"],"gpt_icon":0},{"id":"2481923145","title":"Q3 2024 Amylyx Pharmaceuticals Inc Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2481923145","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481923145?lang=en_us&edition=fundamental","pubTime":"2024-11-08 14:33","pubTimestamp":1731047621,"startTime":"0","endTime":"0","summary":"Lindsey Allen; IR Contact Officer; Amylyx Pharmaceuticals Inc. Justin Klee; Co-Chief Executive Officer, Director; Amylyx Pharmaceuticals Inc. James Frates; Chief Financial Officer; Amylyx Pharmaceuticals Corp. Good morning and thank you all for joining us. The last few months have been productive in advancing our late-stage pipeline in the effort to fulfill our mission to bring new potential treatments to communities with high unmet needs in neurodegenerative diseases and endocrine conditions. We continue to progress our lead asset of avexitide, a GLP-1 receptor antagonist with both FDA breakthrough therapy and orphan drug designations and diseases with no approved treatment options. We remain on track to initiate our phase ||| trial in post bariatric hypoglycemia or PBH in the first quarter of 2025 which Camille will discuss a little later. We have also significantly increased our interactions with the endocrine and PBH communities and are excited for the potential of this therapy.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q3-2024-amylyx-pharmaceuticals-inc-063341962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AMLX"],"gpt_icon":0},{"id":"2481136417","title":"Amylyx Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2481136417","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481136417?lang=en_us&edition=fundamental","pubTime":"2024-11-08 01:20","pubTimestamp":1731000000,"startTime":"0","endTime":"0","summary":"* Amylyx Pharmaceuticals Inc    reported a quarterly adjusted loss of $1.07 per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of 30 cen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX"],"gpt_icon":0},{"id":"2481909174","title":"BRIEF-Amylyx Pharmaceuticals Reports Q3 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2481909174","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481909174?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:50","pubTimestamp":1730983850,"startTime":"0","endTime":"0","summary":"BRIEF-Amylyx Pharmaceuticals Reports Q3 2024 Financial ResultsNov 7 (Reuters) - Amylyx Pharmaceuticals Inc AMLX.O:AMYLYX PHARMACEUTICALS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTSAMYLYX PHARMACEUTIC","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nTUA55VW17:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2481906078","title":"Amylyx Pharma Q3 2024 Adj. EPS $(0.53) Beats $(0.71) Estimate, Sales $416.000K Down From $102.693M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2481906078","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481906078?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:41","pubTimestamp":1730983296,"startTime":"0","endTime":"0","summary":"Amylyx Pharma (NASDAQ:AMLX) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.71) by 25.35 percent.  The company reported $416.000 thousand in sales this quarter. This is a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41804485/amylyx-pharma-q3-2024-adj-eps-0-53-beats-0-71-estimate-sales-416-000k-down-from-102-693m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Amylyx Pharma Q3 2024 Adj. EPS $(0.53) Beats $(0.71) Estimate, Sales $416.000K Down From $102.693M YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX"],"gpt_icon":0},{"id":"2481909593","title":"Amylyx Pharmaceuticals Inc: Cash Runway Expected Into 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2481909593","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481909593?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:00","pubTimestamp":1730980804,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nTUA55VW17:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2481190597","title":"Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2481190597","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481190597?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:00","pubTimestamp":1730980800,"startTime":"0","endTime":"0","summary":"On track to initiate a Phase 3 program for Company’s lead asset avexitide, a GLP-1 receptor antagonist with FDA Breakthrough Therapy and Orphan Drug Designations, in post-bariatric hypoglycemia  in the first quarter of 2025. Reported positive topline data from Phase 2 HELIOS clinical trial of AMX0035 in Wolfram syndrome demonstrating improvement or stabilization across all disease measures at Week 24 and sustained improvement at Weeks 36 and 48. Cash, cash equivalents and marketable securities of $234.4 million as of September 30, 2024; cash runway expected into 2026. Management to host conference call and webcast today at 8:00 a.m. Eastern Time","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/R6mWST0Uiw5I72IajriwwA--~B/aD01ODg7dz0yNTE3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/570450fc193c48c5d1e5b851819c3ede","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/R6mWST0Uiw5I72IajriwwA--~B/aD01ODg7dz0yNTE3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/570450fc193c48c5d1e5b851819c3ede"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amylyx-pharmaceuticals-reports-third-quarter-120000575.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AMLX","BK4211","BK4161","PBH","CSF","BK4007","LU0128526141.USD","LU2360032135.SGD","LU2125154935.USD","PSP","PB","HI","LU0029874061.USD","LU2125154778.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":65,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AMLX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-04","symbol":"AMLX","fiscalQuarterEnding":"2024/12","expectedEps":-0.49,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741064400000,"reportTimeType":"pre","actualEps":-0.55},{"market":"US","date":"2024-11-07","symbol":"AMLX","fiscalQuarterEnding":"2024/09","expectedEps":-0.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.53},{"market":"US","date":"2024-08-08","symbol":"AMLX","fiscalQuarterEnding":"2024/06","expectedEps":-0.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.73},{"market":"US","date":"2024-05-09","symbol":"AMLX","fiscalQuarterEnding":"2024/03","expectedEps":0.24,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-0.46},{"market":"US","date":"2024-02-22","symbol":"AMLX","fiscalQuarterEnding":"2023/12","expectedEps":0.2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1708578000000,"reportTimeType":"pre","actualEps":0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AMLX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AMLX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.3333,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":6,"updateTime":1744084800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AMLX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AMLX","date":"2025-04-22","current":-1.242078,"percent":0.695381,"low":-27.24786,"twenty":-13.362502,"median":-9.00717,"eighty":-0.913571,"high":660.566108,"avg":39.506526,"sd":154.77466,"marketCap":374788439},"quantilePoints":[{"date":"2022-01-07","current":-14.965618,"twenty":-15.735846,"median":-15.735846,"eighty":-15.273709,"marketCap":1020340854},{"date":"2022-01-14","current":-17.069252,"twenty":-16.953304,"median":-16.183076,"eighty":-15.273709,"marketCap":1163764527},{"date":"2022-01-21","current":-15.338309,"twenty":-17.016247,"median":-16.328011,"eighty":-15.417816,"marketCap":1045750560},{"date":"2022-01-28","current":-16.564048,"twenty":-16.799258,"median":-16.025717,"eighty":-15.619898,"marketCap":1129320260},{"date":"2022-02-04","current":-18.651119,"twenty":-18.372842,"median":-16.597176,"eighty":-15.696092,"marketCap":1271614612},{"date":"2022-02-11","current":-15.942897,"twenty":-17.579425,"median":-16.564048,"eighty":-15.735846,"marketCap":1086970750},{"date":"2022-02-18","current":-21.939082,"twenty":-18.462288,"median":-16.667574,"eighty":-15.754066,"marketCap":1495784684},{"date":"2022-02-25","current":-25.657711,"twenty":-19.073502,"median":-16.791804,"eighty":-15.826948,"marketCap":1749317082},{"date":"2022-03-04","current":-22.684464,"twenty":-21.939082,"median":-17.052688,"eighty":-15.942897,"marketCap":1546604096},{"date":"2022-03-11","current":-21.541545,"twenty":-22.684464,"median":-17.512341,"eighty":-16.025717,"marketCap":1468680998},{"date":"2022-03-18","current":-18.841605,"twenty":-22.361465,"median":-18.560016,"eighty":-16.24105,"marketCap":1284601795},{"date":"2022-03-25","current":-20.705061,"twenty":-21.939082,"median":-18.237018,"eighty":-16.28246,"marketCap":1411650325},{"date":"2022-04-01","current":-8.475859,"twenty":-21.905954,"median":-17.624148,"eighty":-15.826948,"marketCap":745290715},{"date":"2022-04-08","current":-8.982567,"twenty":-21.541545,"median":-17.06097,"eighty":-15.603334,"marketCap":789846138},{"date":"2022-04-14","current":-7.771731,"twenty":-21.528294,"median":-16.965727,"eighty":-13.72994,"marketCap":683376036},{"date":"2022-04-22","current":-6.560894,"twenty":-20.869045,"median":-16.804227,"eighty":-9.310283,"marketCap":576905934},{"date":"2022-04-29","current":-5.922572,"twenty":-20.605676,"median":-16.667574,"eighty":-8.660117,"marketCap":520777674},{"date":"2022-05-06","current":-5.034186,"twenty":-19.593613,"median":-16.564048,"eighty":-7.877021,"marketCap":442661022},{"date":"2022-05-13","current":-4.079021,"twenty":-19.267301,"median":-16.261755,"eighty":-7.076815,"marketCap":494605759},{"date":"2022-05-20","current":-4.199702,"twenty":-19.20767,"median":-15.942897,"eighty":-6.639861,"marketCap":509239066},{"date":"2022-05-27","current":-4.23832,"twenty":-19.098348,"median":-15.735846,"eighty":-6.288455,"marketCap":513921724},{"date":"2022-06-03","current":-5.961646,"twenty":-19.02381,"median":-15.644744,"eighty":-5.98953,"marketCap":722885341},{"date":"2022-06-10","current":-6.531261,"twenty":-18.965835,"median":-14.965618,"eighty":-5.946016,"marketCap":791954547},{"date":"2022-06-17","current":-8.606975,"twenty":-18.884671,"median":-12.812292,"eighty":-5.98953,"marketCap":1043647419},{"date":"2022-06-24","current":-9.031773,"twenty":-18.838292,"median":-9.572716,"eighty":-6.047604,"marketCap":1095156658},{"date":"2022-07-01","current":-9.398643,"twenty":-18.760441,"median":-9.500016,"eighty":-6.16474,"marketCap":1139641910},{"date":"2022-07-08","current":-10.721308,"twenty":-18.632898,"median":-9.557942,"eighty":-6.256367,"marketCap":1300022949},{"date":"2022-07-15","current":-9.89585,"twenty":-18.528544,"median":-9.681037,"eighty":-6.279867,"marketCap":1199931133},{"date":"2022-07-22","current":-10.644072,"twenty":-18.336402,"median":-9.891022,"eighty":-6.326623,"marketCap":1290657633},{"date":"2022-07-29","current":-13.028731,"twenty":-18.053157,"median":-10.004462,"eighty":-6.460206,"marketCap":1579811769},{"date":"2022-08-05","current":-12.029491,"twenty":-17.90905,"median":-10.243411,"eighty":-6.531923,"marketCap":1458647991},{"date":"2022-08-12","current":-9.562145,"twenty":-17.579425,"median":-10.400296,"eighty":-6.536805,"marketCap":1466842643},{"date":"2022-08-19","current":-9.485831,"twenty":-17.334277,"median":-10.06963,"eighty":-6.548772,"marketCap":1455135998},{"date":"2022-08-26","current":-10.039108,"twenty":-17.065939,"median":-9.989202,"eighty":-6.580636,"marketCap":1540009176},{"date":"2022-09-02","current":-6.898786,"twenty":-17.03778,"median":-9.89585,"eighty":-6.660919,"marketCap":1058280726},{"date":"2022-09-09","current":-11.401313,"twenty":-16.97815,"median":-9.89585,"eighty":-6.659603,"marketCap":1748972792},{"date":"2022-09-16","current":-11.210528,"twenty":-16.953304,"median":-9.989202,"eighty":-6.666184,"marketCap":1719706179},{"date":"2022-09-23","current":-10.634357,"twenty":-16.878765,"median":-10.096343,"eighty":-6.830104,"marketCap":1631321008},{"date":"2022-09-30","current":-10.741197,"twenty":-16.804227,"median":-10.278624,"eighty":-6.898786,"marketCap":1647710311},{"date":"2022-10-07","current":-13.802176,"twenty":-16.779381,"median":-10.619936,"eighty":-6.916248,"marketCap":2117267640},{"date":"2022-10-14","current":-14.91268,"twenty":-16.704843,"median":-10.68269,"eighty":-6.955732,"marketCap":2287620052},{"date":"2022-10-21","current":-15.663927,"twenty":-16.630305,"median":-10.741197,"eighty":-7.071912,"marketCap":2402862058},{"date":"2022-10-28","current":-15.698467,"twenty":-16.564048,"median":-10.820266,"eighty":-7.107086,"marketCap":2408160541},{"date":"2022-11-04","current":-14.839283,"twenty":-16.564048,"median":-11.050268,"eighty":-7.166312,"marketCap":2276360776},{"date":"2022-11-11","current":-12.241999,"twenty":-16.414972,"median":-11.147569,"eighty":-7.617391,"marketCap":2252711412},{"date":"2022-11-18","current":-12.598457,"twenty":-16.350411,"median":-11.290658,"eighty":-7.771731,"marketCap":2318305067},{"date":"2022-11-25","current":-13.952278,"twenty":-16.29605,"median":-11.35934,"eighty":-7.771731,"marketCap":2567428447},{"date":"2022-12-02","current":-14.125106,"twenty":-16.249332,"median":-11.460456,"eighty":-7.806593,"marketCap":2599231432},{"date":"2022-12-09","current":-12.836096,"twenty":-16.1662,"median":-11.775251,"eighty":-7.885736,"marketCap":2362034171},{"date":"2022-12-16","current":-12.843297,"twenty":-16.050071,"median":-11.935471,"eighty":-8.033728,"marketCap":2363359296},{"date":"2022-12-23","current":-12.803691,"twenty":-15.960795,"median":-12.029491,"eighty":-8.236016,"marketCap":2356071112},{"date":"2022-12-30","current":-13.304172,"twenty":-15.943564,"median":-12.241999,"eighty":-8.385046,"marketCap":2448167255},{"date":"2023-01-06","current":-13.318575,"twenty":-15.896517,"median":-12.362571,"eighty":-8.462395,"marketCap":2450817503},{"date":"2023-01-13","current":-13.498604,"twenty":-15.790507,"median":-12.391845,"eighty":-8.473431,"marketCap":2483945612},{"date":"2023-01-20","current":-13.275368,"twenty":-15.735846,"median":-12.443631,"eighty":-8.502082,"marketCap":2442866757},{"date":"2023-01-27","current":-14.737206,"twenty":-15.72837,"median":-12.465235,"eighty":-8.626816,"marketCap":2711867002},{"date":"2023-02-03","current":-13.192554,"twenty":-15.696004,"median":-12.546391,"eighty":-8.713372,"marketCap":2427627827},{"date":"2023-02-10","current":-12.278005,"twenty":-15.681709,"median":-12.523129,"eighty":-8.748896,"marketCap":2259337033},{"date":"2023-02-17","current":-13.368983,"twenty":-15.658746,"median":-12.575053,"eighty":-8.817175,"marketCap":2460093374},{"date":"2023-02-24","current":-12.425629,"twenty":-15.638022,"median":-12.582254,"eighty":-8.982159,"marketCap":2286502083},{"date":"2023-03-03","current":-12.321212,"twenty":-15.603334,"median":-12.537247,"eighty":-8.982567,"marketCap":2267287779},{"date":"2023-03-10","current":-11.039402,"twenty":-15.534402,"median":-12.530188,"eighty":-9.031773,"marketCap":2031415643},{"date":"2023-03-17","current":-10.186966,"twenty":-15.504179,"median":-12.49404,"eighty":-9.054954,"marketCap":2020839392},{"date":"2023-03-24","current":-9.665679,"twenty":-15.486909,"median":-12.456774,"eighty":-9.147083,"marketCap":1917428991},{"date":"2023-03-31","current":-9.867467,"twenty":-15.435099,"median":-12.43283,"eighty":-9.169128,"marketCap":1957458823},{"date":"2023-04-06","current":-9.352906,"twenty":-15.421283,"median":-12.415671,"eighty":-9.271642,"marketCap":1855382750},{"date":"2023-04-14","current":-10.284497,"twenty":-15.404013,"median":-12.363817,"eighty":-9.314874,"marketCap":2040187145},{"date":"2023-04-21","current":-10.371939,"twenty":-15.352203,"median":-12.317611,"eighty":-9.344721,"marketCap":2057533405},{"date":"2023-04-28","current":-9.540583,"twenty":-15.33867,"median":-12.281606,"eighty":-9.352541,"marketCap":1892613220},{"date":"2023-05-05","current":-9.381574,"twenty":-15.156691,"median":-12.115978,"eighty":-9.37584,"marketCap":1861069667},{"date":"2023-05-12","current":-12.985377,"twenty":-14.994752,"median":-12.108777,"eighty":-9.395229,"marketCap":1934223866},{"date":"2023-05-19","current":-12.108956,"twenty":-14.947446,"median":-12.115978,"eighty":-9.401237,"marketCap":1803677398},{"date":"2023-05-26","current":-11.860914,"twenty":-14.918725,"median":-12.116976,"eighty":-9.404582,"marketCap":1766730562},{"date":"2023-06-02","current":-11.026591,"twenty":-14.881594,"median":-12.108866,"eighty":-9.409977,"marketCap":1642454838},{"date":"2023-06-09","current":-11.838365,"twenty":-14.847918,"median":-12.041308,"eighty":-9.445302,"marketCap":1763371758},{"date":"2023-06-16","current":-11.166396,"twenty":-14.778037,"median":-12.006124,"eighty":-9.4782,"marketCap":1663279418},{"date":"2023-06-23","current":-11.175416,"twenty":-14.689959,"median":-11.960384,"eighty":-9.490139,"marketCap":1664622940},{"date":"2023-06-30","current":-9.461672,"twenty":-14.615348,"median":-11.875318,"eighty":-9.487985,"marketCap":1409353885},{"date":"2023-07-07","current":-9.276768,"twenty":-14.600384,"median":-11.818255,"eighty":-9.461672,"marketCap":1381811698},{"date":"2023-07-14","current":-10.372662,"twenty":-14.560777,"median":-11.775251,"eighty":-9.461672,"marketCap":1545049541},{"date":"2023-07-21","current":-10.106581,"twenty":-14.525026,"median":-11.523392,"eighty":-9.466753,"marketCap":1505415661},{"date":"2023-07-28","current":-10.038933,"twenty":-14.511152,"median":-11.468324,"eighty":-9.484221,"marketCap":1495339251},{"date":"2023-08-04","current":-10.169719,"twenty":-14.445559,"median":-11.399203,"eighty":-9.485831,"marketCap":1514820310},{"date":"2023-08-11","current":-19.589727,"twenty":-14.445559,"median":-11.396399,"eighty":-9.496602,"marketCap":1426386819},{"date":"2023-08-18","current":-18.701388,"twenty":-14.600384,"median":-11.401111,"eighty":-9.500016,"marketCap":1361704186},{"date":"2023-08-25","current":-20.107925,"twenty":-14.86087,"median":-11.504635,"eighty":-9.535435,"marketCap":1464118355},{"date":"2023-09-01","current":-19.950615,"twenty":-15.111286,"median":-11.536747,"eighty":-9.540583,"marketCap":1452664139},{"date":"2023-09-08","current":-19.321375,"twenty":-15.404013,"median":-11.782004,"eighty":-9.55447,"marketCap":1406847273},{"date":"2023-09-15","current":-18.146176,"twenty":-15.510224,"median":-11.838365,"eighty":-9.561304,"marketCap":1321277540},{"date":"2023-09-22","current":-16.730386,"twenty":-15.668372,"median":-11.914636,"eighty":-9.580399,"marketCap":1218189593},{"date":"2023-09-29","current":-17.119034,"twenty":-15.754066,"median":-11.982756,"eighty":-9.586985,"marketCap":1246488245},{"date":"2023-10-06","current":-16.443526,"twenty":-16.050071,"median":-12.0354,"eighty":-9.604096,"marketCap":1197302493},{"date":"2023-10-13","current":-16.29547,"twenty":-16.249332,"median":-12.108777,"eighty":-9.611049,"marketCap":1186522054},{"date":"2023-10-20","current":-15.314596,"twenty":-16.285062,"median":-12.116976,"eighty":-9.618907,"marketCap":1115101646},{"date":"2023-10-27","current":-14.759384,"twenty":-16.274178,"median":-12.163074,"eighty":-9.620949,"marketCap":1074675000},{"date":"2023-11-03","current":-16.674865,"twenty":-16.274178,"median":-12.257781,"eighty":-9.623732,"marketCap":1214146928},{"date":"2023-11-10","current":450.85384,"twenty":-16.339423,"median":-12.267893,"eighty":-9.620949,"marketCap":827767651},{"date":"2023-11-17","current":446.073172,"twenty":-16.292868,"median":-12.208173,"eighty":-9.585468,"marketCap":818990343},{"date":"2023-11-24","current":484.318522,"twenty":-16.28246,"median":-12.115978,"eighty":-9.540583,"marketCap":889208807},{"date":"2023-12-01","current":520.725154,"twenty":-16.24105,"median":-12.108777,"eighty":-9.485831,"marketCap":956051382},{"date":"2023-12-08","current":522.931616,"twenty":-16.175174,"median":-12.029491,"eighty":-9.457162,"marketCap":960102447},{"date":"2023-12-15","current":542.054291,"twenty":-16.147488,"median":-11.981987,"eighty":-9.401886,"marketCap":995211679},{"date":"2023-12-22","current":513.002535,"twenty":-16.036371,"median":-11.889723,"eighty":-9.351083,"marketCap":941872654},{"date":"2023-12-29","current":542.422035,"twenty":-16.030819,"median":-11.849639,"eighty":-9.28907,"marketCap":995886856},{"date":"2024-01-05","current":611.925604,"twenty":-16.026838,"median":-11.798146,"eighty":-9.172617,"marketCap":1123495409},{"date":"2024-01-12","current":596.480367,"twenty":-16.009487,"median":-11.66078,"eighty":-8.992408,"marketCap":1095137953},{"date":"2024-01-19","current":547.202704,"twenty":-15.944565,"median":-11.523392,"eighty":-8.742138,"marketCap":1004664164},{"date":"2024-01-26","current":565.222148,"twenty":-15.942897,"median":-11.468324,"eighty":-8.471813,"marketCap":1037747863},{"date":"2024-02-02","current":609.351398,"twenty":-15.826948,"median":-11.399203,"eighty":-7.903343,"marketCap":1118769167},{"date":"2024-02-09","current":568.531842,"twenty":-15.82354,"median":-11.35934,"eighty":-7.617391,"marketCap":1043824461},{"date":"2024-02-16","current":565.589892,"twenty":-15.749512,"median":-11.333465,"eighty":-6.955732,"marketCap":1038423041},{"date":"2024-02-23","current":25.505487,"twenty":-15.738579,"median":-11.295413,"eighty":-6.79732,"marketCap":1256680857},{"date":"2024-03-01","current":25.931954,"twenty":-15.735846,"median":-11.210528,"eighty":-6.545379,"marketCap":1277693320},{"date":"2024-03-08","current":26.097038,"twenty":-15.705943,"median":-11.186691,"eighty":-6.413487,"marketCap":1285827176},{"date":"2024-03-15","current":4.360971,"twenty":-15.688617,"median":-11.153292,"eighty":-6.087088,"marketCap":214869380},{"date":"2024-03-22","current":3.94826,"twenty":-15.668372,"median":-11.128797,"eighty":-5.859309,"marketCap":194534738},{"date":"2024-03-28","current":3.962017,"twenty":-15.648384,"median":-11.044835,"eighty":-4.906998,"marketCap":195212560},{"date":"2024-04-05","current":3.590578,"twenty":-15.617209,"median":-11.017571,"eighty":-4.329072,"marketCap":176911382},{"date":"2024-04-12","current":3.150354,"twenty":-15.591102,"median":-10.839424,"eighty":-4.211287,"marketCap":155221098},{"date":"2024-04-19","current":2.723887,"twenty":-15.55382,"median":-10.788969,"eighty":-4.079021,"marketCap":134208635},{"date":"2024-04-26","current":2.456825,"twenty":-15.516268,"median":-10.74692,"eighty":-3.715047,"marketCap":121050233},{"date":"2024-05-03","current":2.760478,"twenty":-15.493817,"median":-10.721308,"eighty":2.527963,"marketCap":136011498},{"date":"2024-05-10","current":-1.807875,"twenty":-15.455823,"median":-10.639214,"eighty":2.639017,"marketCap":128530865},{"date":"2024-05-17","current":-1.750482,"twenty":-15.424737,"median":-10.575606,"eighty":2.605891,"marketCap":124450520},{"date":"2024-05-24","current":-1.702655,"twenty":-15.407467,"median":-10.55061,"eighty":2.581476,"marketCap":121050233},{"date":"2024-05-31","current":-1.607,"twenty":-15.376381,"median":-10.462744,"eighty":2.542829,"marketCap":114249658},{"date":"2024-06-07","current":-1.683524,"twenty":-15.339392,"median":-10.375302,"eighty":2.481669,"marketCap":119690118},{"date":"2024-06-14","current":-1.607,"twenty":-15.333566,"median":-10.371939,"eighty":2.451304,"marketCap":114249658},{"date":"2024-06-21","current":-1.578303,"twenty":-15.314596,"median":-10.345603,"eighty":2.42922,"marketCap":112209485},{"date":"2024-06-28","current":-1.846137,"twenty":-15.233272,"median":-10.336583,"eighty":0.837689,"marketCap":131251095},{"date":"2024-07-05","current":-1.693089,"twenty":-15.107531,"median":-10.295995,"eighty":-1.553433,"marketCap":120370175},{"date":"2024-07-12","current":-2.180928,"twenty":-15.067132,"median":-10.277956,"eighty":-1.570651,"marketCap":155053107},{"date":"2024-07-15","current":-2.066143,"twenty":-15.041754,"median":-10.273446,"eighty":-1.572564,"marketCap":146892417},{"date":"2024-08-02","current":-1.980053,"twenty":-15.016375,"median":-10.2672,"eighty":-1.574477,"marketCap":140771900},{"date":"2024-08-09","current":-0.738827,"twenty":-14.951989,"median":-10.237413,"eighty":-1.574477,"marketCap":122548442},{"date":"2024-08-16","current":-0.886592,"twenty":-14.924769,"median":-10.186966,"eighty":-0.851292,"marketCap":147058130},{"date":"2024-08-23","current":-0.91122,"twenty":-14.881594,"median":-10.176877,"eighty":-0.87551,"marketCap":151143078},{"date":"2024-08-30","current":-0.870174,"twenty":-14.847918,"median":-10.167464,"eighty":-0.872636,"marketCap":144334832},{"date":"2024-09-06","current":-0.90301,"twenty":-14.807323,"median":-10.14717,"eighty":-0.871816,"marketCap":149781429},{"date":"2024-09-13","current":-1.022044,"twenty":-14.750513,"median":-10.111091,"eighty":-0.874278,"marketCap":169525345},{"date":"2024-09-20","current":-1.182123,"twenty":-14.689959,"median":-10.097576,"eighty":-0.875099,"marketCap":196077507},{"date":"2024-09-27","current":-1.31347,"twenty":-14.611607,"median":-10.070502,"eighty":-0.880435,"marketCap":217863897},{"date":"2024-10-04","current":-1.20675,"twenty":-14.591806,"median":-10.05255,"eighty":-0.886592,"marketCap":200162455},{"date":"2024-10-11","current":-1.420189,"twenty":-14.573388,"median":-9.984815,"eighty":-0.893159,"marketCap":235565339},{"date":"2024-10-18","current":-1.609,"twenty":-14.563346,"median":-9.930486,"eighty":-0.90301,"marketCap":266883274},{"date":"2024-10-25","current":-2.01125,"twenty":-14.546477,"median":-9.907825,"eighty":-0.904652,"marketCap":333604093},{"date":"2024-10-31","current":-2.16312,"twenty":-14.522251,"median":-9.891022,"eighty":-0.907936,"marketCap":358794606},{"date":"2024-11-08","current":-1.71606,"twenty":-14.498033,"median":-9.867467,"eighty":-0.91122,"marketCap":445259340},{"date":"2024-11-15","current":-1.317221,"twenty":-14.412048,"median":-9.847288,"eighty":-0.912041,"marketCap":341773989},{"date":"2024-11-22","current":-1.361828,"twenty":-14.258948,"median":-9.820895,"eighty":-0.917787,"marketCap":353348008},{"date":"2024-11-29","current":-1.453666,"twenty":-14.182716,"median":-9.792708,"eighty":-0.927638,"marketCap":377176872},{"date":"2024-12-06","current":-1.304101,"twenty":-14.161433,"median":-9.786381,"eighty":-0.927638,"marketCap":338369865},{"date":"2024-12-13","current":-1.15716,"twenty":-14.135908,"median":-9.753975,"eighty":-0.972788,"marketCap":300243683},{"date":"2024-12-20","current":-1.039082,"twenty":-14.125106,"median":-9.730036,"eighty":-1.022044,"marketCap":269606573},{"date":"2024-12-27","current":-1.067946,"twenty":-14.113584,"median":-9.665679,"eighty":-1.031477,"marketCap":277095644},{"date":"2025-01-03","current":-1.025963,"twenty":-14.015648,"median":-9.642275,"eighty":-1.012318,"marketCap":266202449},{"date":"2025-01-10","current":-0.989228,"twenty":-13.942196,"median":-9.632047,"eighty":-1.007595,"marketCap":256670904},{"date":"2025-01-17","current":-0.918381,"twenty":-13.90403,"median":-9.621327,"eighty":-0.945698,"marketCap":238288638},{"date":"2025-01-24","current":-0.934125,"twenty":-13.865081,"median":-9.609998,"eighty":-0.927638,"marketCap":242373586},{"date":"2025-01-31","current":-0.921005,"twenty":-13.841127,"median":-9.584963,"eighty":-0.918381,"marketCap":238969462},{"date":"2025-02-07","current":-0.98398,"twenty":-13.8128,"median":-9.549263,"eighty":-0.918381,"marketCap":255309255},{"date":"2025-02-14","current":-0.941996,"twenty":-13.770986,"median":-9.500016,"eighty":-0.918381,"marketCap":244416060},{"date":"2025-02-21","current":-0.923629,"twenty":-13.646228,"median":-9.485831,"eighty":-0.918381,"marketCap":239650287},{"date":"2025-02-28","current":-0.829167,"twenty":-13.53821,"median":-9.464213,"eighty":-0.913133,"marketCap":215140598},{"date":"2025-03-07","current":-0.814527,"twenty":-13.520208,"median":-9.457162,"eighty":-0.907115,"marketCap":245777709},{"date":"2025-03-14","current":-1.077642,"twenty":-13.509406,"median":-9.403571,"eighty":-0.905261,"marketCap":325171057},{"date":"2025-03-21","current":-1.095261,"twenty":-13.498604,"median":-9.381574,"eighty":-0.907115,"marketCap":330487205},{"date":"2025-03-28","current":-1.13637,"twenty":-13.4734,"median":-9.335179,"eighty":-0.907885,"marketCap":342891551},{"date":"2025-04-04","current":-1.030661,"twenty":-13.401388,"median":-9.276768,"eighty":-0.91122,"marketCap":310994662},{"date":"2025-04-11","current":-1.024788,"twenty":-13.390586,"median":-9.158106,"eighty":-0.91122,"marketCap":309222613},{"date":"2025-04-17","current":-1.121688,"twenty":-13.373304,"median":-9.043363,"eighty":-0.91275,"marketCap":338461427},{"date":"2025-04-22","current":-1.242078,"twenty":-13.362502,"median":-9.00717,"eighty":-0.913571,"marketCap":374788439}],"updateTime":1745410590718}}}